Categories
Uncategorized

Pt.2: Vaccines Not Silver Bullets- A Fact Realized Sooner With More Scientific Debate

Before we continue on it should be stated that this article covers the repurposing of known medications to treat the virus. Fluvoxamine is discussed at the beginning. It’s an anti depressant (SSRI) with anti viral properties

You can see the Ontario Science Table Recommendation here

It is a recommendation that comes with qualifiers, however, there were studies that demonstrated very good outcomes. See the Lancet– unlike the jab. Mr Doidge discusses the politicization of repurposed drugs. HCQ, in particular. Seemingly endorsed by Donald Trump so reviled by those whose thinking was impaired by their hatred of this individual. Ivermectin is mentioned in the article as well.

Think about the Amygdala and Fear: Many of the symptoms like brain fog and in ability to think are caused by excess stimulation of our fear reactions- sounds a bit like ‘long covid

So we begin with more excerpts:

We are especially suspicious of other people during contagion, because our brains are fired up by a primitive circuit that protects us by making us obsessively preoccupied with the purity of those around us. Will this person get me sick? It even fires if we think their actions, or even policy proposals might be risky. The circuit, called the behavioural immune system, causes us to fear, loathe and feel rage toward the “impure” germ bearer. It results in many false alarms (think of someone driving alone with a mask on). It’s one reason debates about vaccines are emotionally radioactive. Some vaccinated people feel all the unvaccinated bear germs, while some unvaccinated people feel vaccine may put germs or toxins in their bodies.

A nurse administers a COVID-19 vaccine in Orange, Calif., this past summer.Jae C. Hong/The Associated Press

This past summer, as news broke that there were breakthrough infections and vaccine protection against infection was waning, the North American media began to advise us to lower our expectations for them: “Vaccines Can Only Do So Much,” read a headline in The Washington Post. Many readers were caught completely off guard. In part they were surprised, because the censorship of scientists who held dissenting views – and had been warning this might happen – was much more widespread than many are aware of.

Speaking for myself, I was not caught by surprise or taken unaware. In fact this had been my expectation. Having written about this topic on numerous occasions in 2020. See below a flashback to an October 28/2020 report from my google censored site!

According to an Amnesty International report published in October, censorship and harassment of health professionals, and others, has been a problem “across the world,” during the pandemic. Most singled out are those who express critical opinions of their governments’ policies (e.g. restrictions of movement, lockdown, or criticisms of government dispensing with civil liberties).

The censors justified these actions as simply banning “misinformation” and “prevent[ing] panic.” In North America people were not imprisoned, but many brilliant scientists and physicians with proper credentials from places such as Harvard, Oxford and Stanford, were under fire. Physicians were vilified for questioning government policies on lockdowns, masks, aspects of vaccines, mitigation or unproven treatments – the very things that were, of course, the subject of serious continuing scientific debate. In some jurisdictions in North America physicians are threatened by their regulating boards with suspension or revocation of their medical licenses for spreading “misinformation,” forcing some doctors to have to choose between what they – rightly or wrongly – see as their patient’s best interests, and their own livelihood.

The attack on Doctors has occurred right here in my home province. As for the censorship? That was suffered by myself first hand!

The authors of the master narrative tend to say the main reason that things have not gone as they predicted is because variants arose. But if anything could have been predicted, it is that viruses mutate. Columbia virologist Vincent Racaniello described how fellow scientists were worried that the new mRNA technology, by focusing on only a small portion of the virus, the spike protein, would make it easy for the virus to “get around” or escape the vaccine through mutations. “That’s partly why,” he said in May, “all the variants are arising now, because we have only the spike epitopes in there.” That view didn’t get much of a hearing.

The vaccines encouraged the variety/speed of the new variants? Possible. Entirely, possible.

It wasn’t just the variants’ role in declining vaccine efficacy that surprised people. There was something about the execution of the original clinical trials, conducted by the pharma companies themselves, on their own products that also led to this surprise. It’s worth going back for a moment and looking at how the problem unfolded.

In December, 2020, the new mRNA vaccines were rolled out, and were, according to the randomized clinical trials, 95 per cent (Pfizer) and 94.5 per cent (Moderna) efficacious in stopping infection. Physician-scientist Eric Topol, head of Scripps Labs, said these vaccines “will go down in history as one of science and medical research’s greatest achievements.”

But by the time summer 2021 arrived, real world experience contradicted Mr. Bourla’s and Dr. Sahin’s claims of potency at six months, no transmission by the vaccinated, and imminent herd immunity. Pfizer’s Mr. Bourla, in his February interview, had called Israel “the world’s lab,” because it was vaccinated with the Pfizer extensively and several months ahead of other countries, giving the world a glimpse of its future. But when Israeli public health released its six-month data, they showed that vaccine effectiveness had dropped to 39 per cent, and Delta was surging. (The FDA had originally said it would not approve a vaccine less than 50-per-cent effective.) A Mayo clinic study showed that after six months, protection granted by the two Pfizer doses dropped from the original 95 per cent to 42 per cent. Another Israeli study showed it had dropped to 16 per cent. That huge discrepancy couldn’t be attributed just to the new variant, Delta, because protection was already fading at five months for the earlier variants too.

So why such a discrepancy? The original studies were clinical trials. The Pfizer study followed about 38,000 people without COVID who were divided in two groups – half got the vaccine, and half a placebo. The investigators asked the question: could the vaccines prevent symptomatic cases of COVID-19? But, as Peter Doshi, senior editor at the British Medical Journal, warned, “None of the trials currently under way are designed to detect a reduction in any serious outcome such as hospital admissions, use of intensive care, or deaths.” He explained that, “Because most people with symptomatic COVID-19 experience only mild symptoms, even trials involving 30,000 or more patients would turn up relatively few cases of severe disease. Susanne Hodgson of the University of Oxford agreed: “The current [randomized control trials] that are ongoing are … not powered to assess efficacy against hospital admission and death.”

Brian left the link for this latest article from Mr Peter Doshi@ BMJ- Covid-19 vaccines and treatments: we must have raw data, now

Pt 3 will be up shortly

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: